IL6 and neoplasm: The main mechanism involves the activation of HIF-1α or oncogenes (such as RAS) by hypoxia or inflammatory factors (such as IL-6 and TNF-α) in the tumor microenvironment, leading to the secretion of VEGF, mainly VEGF-A (Song et al., 2023).